A Population-based Cohort in Northern Spain

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-69
SponsorInstituto de Investigación Marqués de Valdecilla

About this trial

Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional Goverment. Its aim is to identify and follow up a cohort that would provide information to improve the understanding of the etiology and prognosis of different acute and chronic diseases. The Cantabria Cohort will recruit between 40,000-50,000 residents aged 40-69 years at baseline, representing 10-20% of the target population. Currently, more than 22,000 volunteers have been enrolled. All participants will be invited for a re-assessment every three years, while the overall duration is planned for twenty years. The repeated collection of biomaterials combined with broad information from participant questionnaires, medical examinations, actual health system records and other secondary public data sources is a major strength of its design, which will make it possible to address biological pathways of disease development, identify new factors involved in health and disease, design new strategies for disease prevention, and advance precision medicine. It is conceived to allow access to a large number of researchers worldwide to boost collaboration and medical research.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participants between 40-69 years of age

Participants who sign the informed consent form

Participants legally residing in Cantabria

Disqualifiers

Participants under 40 years of age and over 69 years of age

Participants not signing the informed consent form

Participants not legally residing in Cantabria

Trial population

Residents in the autonomous community of Cantabria

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • cohort

    Other intervention

    The Cantabria Cohort will recruit 40,000-50,000 residents aged 40-69 years at baseline

Treatment groups

22,000 Participants
are divided into 1 treatment group
Group A: Patient registry1 intervention

Trial outcomes

Primary outcomes

1

Integration and use of real-world data to improve health research

Time frame
20 years
2

Identifying lifestyle risk factors and their involvement in chronic diseases

Time frame
20 years
3

Evaluation of geographic and socio-economic disparities in health and healthcare

Time frame
20 years
4

Assessing biomarkers for the early detection of diseases and disease risks

Time frame
20 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.